abstract |
The present invention provides ocular scaffolds composed of poly (e-caprolactone) configured to be inserted into the sub-retinal space of a subject, as well as methods for treating eye disease (e.g., age-related macular degeneration) with such scaffolds. The present invention also provides methods of making such scaffolds. |